Global Drugs Based on CAR T-cell Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Drugs Based on CAR T-cell market size was valued at US$ 5337 million in 2024 and is forecast to a readjusted size of USD 31500 million by 2031 with a CAGR of 29.2% during review period.

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient"s own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.

This report is a detailed and comprehensive analysis for global Drugs Based on CAR T-cell market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Drugs Based on CAR T-cell market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drugs Based on CAR T-cell market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drugs Based on CAR T-cell market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drugs Based on CAR T-cell market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drugs Based on CAR T-cell
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drugs Based on CAR T-cell market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Drugs Based on CAR T-cell market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    CD19-targeted
    BCMA-targeted

Market segment by Application
    Lymphoma
    Multiple Myeloma

Market segment by players, this report covers
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drugs Based on CAR T-cell product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drugs Based on CAR T-cell, with revenue, gross margin, and global market share of Drugs Based on CAR T-cell from 2020 to 2025.
Chapter 3, the Drugs Based on CAR T-cell competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drugs Based on CAR T-cell market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs Based on CAR T-cell.
Chapter 13, to describe Drugs Based on CAR T-cell research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Drugs Based on CAR T-cell by Type
        1.3.1 Overview: Global Drugs Based on CAR T-cell Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Drugs Based on CAR T-cell Consumption Value Market Share by Type in 2024
        1.3.3 CD19-targeted
        1.3.4 BCMA-targeted
    1.4 Global Drugs Based on CAR T-cell Market by Application
        1.4.1 Overview: Global Drugs Based on CAR T-cell Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Lymphoma
        1.4.3 Multiple Myeloma
    1.5 Global Drugs Based on CAR T-cell Market Size & Forecast
    1.6 Global Drugs Based on CAR T-cell Market Size and Forecast by Region
        1.6.1 Global Drugs Based on CAR T-cell Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Drugs Based on CAR T-cell Market Size by Region, (2020-2031)
        1.6.3 North America Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
        1.6.4 Europe Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
        1.6.6 South America Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Drugs Based on CAR T-cell Product and Solutions
        2.1.4 Novartis Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences Drugs Based on CAR T-cell Product and Solutions
        2.2.4 Gilead Sciences Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Gilead Sciences Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Product and Solutions
        2.3.4 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 J & J
        2.4.1 J & J Details
        2.4.2 J & J Major Business
        2.4.3 J & J Drugs Based on CAR T-cell Product and Solutions
        2.4.4 J & J Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 J & J Recent Developments and Future Plans
    2.5 JW Therapeutics
        2.5.1 JW Therapeutics Details
        2.5.2 JW Therapeutics Major Business
        2.5.3 JW Therapeutics Drugs Based on CAR T-cell Product and Solutions
        2.5.4 JW Therapeutics Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 JW Therapeutics Recent Developments and Future Plans
    2.6 FOSUNKite
        2.6.1 FOSUNKite Details
        2.6.2 FOSUNKite Major Business
        2.6.3 FOSUNKite Drugs Based on CAR T-cell Product and Solutions
        2.6.4 FOSUNKite Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 FOSUNKite Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Drugs Based on CAR T-cell Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Drugs Based on CAR T-cell by Company Revenue
        3.2.2 Top 3 Drugs Based on CAR T-cell Players Market Share in 2024
        3.2.3 Top 6 Drugs Based on CAR T-cell Players Market Share in 2024
    3.3 Drugs Based on CAR T-cell Market: Overall Company Footprint Analysis
        3.3.1 Drugs Based on CAR T-cell Market: Region Footprint
        3.3.2 Drugs Based on CAR T-cell Market: Company Product Type Footprint
        3.3.3 Drugs Based on CAR T-cell Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Drugs Based on CAR T-cell Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Drugs Based on CAR T-cell Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Drugs Based on CAR T-cell Consumption Value Market Share by Application (2020-2025)
    5.2 Global Drugs Based on CAR T-cell Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
    6.2 North America Drugs Based on CAR T-cell Market Size by Application (2020-2031)
    6.3 North America Drugs Based on CAR T-cell Market Size by Country
        6.3.1 North America Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
        6.3.2 United States Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        6.3.3 Canada Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        6.3.4 Mexico Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
    7.2 Europe Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
    7.3 Europe Drugs Based on CAR T-cell Market Size by Country
        7.3.1 Europe Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
        7.3.2 Germany Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        7.3.3 France Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        7.3.5 Russia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        7.3.6 Italy Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Drugs Based on CAR T-cell Market Size by Region
        8.3.1 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Region (2020-2031)
        8.3.2 China Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        8.3.3 Japan Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        8.3.4 South Korea Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        8.3.5 India Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        8.3.7 Australia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
    9.2 South America Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
    9.3 South America Drugs Based on CAR T-cell Market Size by Country
        9.3.1 South America Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
        9.3.2 Brazil Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        9.3.3 Argentina Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Drugs Based on CAR T-cell Market Size by Country
        10.3.1 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
        10.3.2 Turkey Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
        10.3.4 UAE Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Drugs Based on CAR T-cell Market Drivers
    11.2 Drugs Based on CAR T-cell Market Restraints
    11.3 Drugs Based on CAR T-cell Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Drugs Based on CAR T-cell Industry Chain
    12.2 Drugs Based on CAR T-cell Upstream Analysis
    12.3 Drugs Based on CAR T-cell Midstream Analysis
    12.4 Drugs Based on CAR T-cell Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Drugs Based on CAR T-cell Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Drugs Based on CAR T-cell Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Drugs Based on CAR T-cell Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Drugs Based on CAR T-cell Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Novartis Company Information, Head Office, and Major Competitors
 Table 6. Novartis Major Business
 Table 7. Novartis Drugs Based on CAR T-cell Product and Solutions
 Table 8. Novartis Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Novartis Recent Developments and Future Plans
 Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
 Table 11. Gilead Sciences Major Business
 Table 12. Gilead Sciences Drugs Based on CAR T-cell Product and Solutions
 Table 13. Gilead Sciences Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Gilead Sciences Recent Developments and Future Plans
 Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
 Table 16. Bristol-Myers Squibb Major Business
 Table 17. Bristol-Myers Squibb Drugs Based on CAR T-cell Product and Solutions
 Table 18. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. J & J Company Information, Head Office, and Major Competitors
 Table 20. J & J Major Business
 Table 21. J & J Drugs Based on CAR T-cell Product and Solutions
 Table 22. J & J Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. J & J Recent Developments and Future Plans
 Table 24. JW Therapeutics Company Information, Head Office, and Major Competitors
 Table 25. JW Therapeutics Major Business
 Table 26. JW Therapeutics Drugs Based on CAR T-cell Product and Solutions
 Table 27. JW Therapeutics Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. JW Therapeutics Recent Developments and Future Plans
 Table 29. FOSUNKite Company Information, Head Office, and Major Competitors
 Table 30. FOSUNKite Major Business
 Table 31. FOSUNKite Drugs Based on CAR T-cell Product and Solutions
 Table 32. FOSUNKite Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. FOSUNKite Recent Developments and Future Plans
 Table 34. Global Drugs Based on CAR T-cell Revenue (USD Million) by Players (2020-2025)
 Table 35. Global Drugs Based on CAR T-cell Revenue Share by Players (2020-2025)
 Table 36. Breakdown of Drugs Based on CAR T-cell by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 37. Market Position of Players in Drugs Based on CAR T-cell, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 38. Head Office of Key Drugs Based on CAR T-cell Players
 Table 39. Drugs Based on CAR T-cell Market: Company Product Type Footprint
 Table 40. Drugs Based on CAR T-cell Market: Company Product Application Footprint
 Table 41. Drugs Based on CAR T-cell New Market Entrants and Barriers to Market Entry
 Table 42. Drugs Based on CAR T-cell Mergers, Acquisition, Agreements, and Collaborations
 Table 43. Global Drugs Based on CAR T-cell Consumption Value (USD Million) by Type (2020-2025)
 Table 44. Global Drugs Based on CAR T-cell Consumption Value Share by Type (2020-2025)
 Table 45. Global Drugs Based on CAR T-cell Consumption Value Forecast by Type (2026-2031)
 Table 46. Global Drugs Based on CAR T-cell Consumption Value by Application (2020-2025)
 Table 47. Global Drugs Based on CAR T-cell Consumption Value Forecast by Application (2026-2031)
 Table 48. North America Drugs Based on CAR T-cell Consumption Value by Type (2020-2025) & (USD Million)
 Table 49. North America Drugs Based on CAR T-cell Consumption Value by Type (2026-2031) & (USD Million)
 Table 50. North America Drugs Based on CAR T-cell Consumption Value by Application (2020-2025) & (USD Million)
 Table 51. North America Drugs Based on CAR T-cell Consumption Value by Application (2026-2031) & (USD Million)
 Table 52. North America Drugs Based on CAR T-cell Consumption Value by Country (2020-2025) & (USD Million)
 Table 53. North America Drugs Based on CAR T-cell Consumption Value by Country (2026-2031) & (USD Million)
 Table 54. Europe Drugs Based on CAR T-cell Consumption Value by Type (2020-2025) & (USD Million)
 Table 55. Europe Drugs Based on CAR T-cell Consumption Value by Type (2026-2031) & (USD Million)
 Table 56. Europe Drugs Based on CAR T-cell Consumption Value by Application (2020-2025) & (USD Million)
 Table 57. Europe Drugs Based on CAR T-cell Consumption Value by Application (2026-2031) & (USD Million)
 Table 58. Europe Drugs Based on CAR T-cell Consumption Value by Country (2020-2025) & (USD Million)
 Table 59. Europe Drugs Based on CAR T-cell Consumption Value by Country (2026-2031) & (USD Million)
 Table 60. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Type (2020-2025) & (USD Million)
 Table 61. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Type (2026-2031) & (USD Million)
 Table 62. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Application (2020-2025) & (USD Million)
 Table 63. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Application (2026-2031) & (USD Million)
 Table 64. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Region (2020-2025) & (USD Million)
 Table 65. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Region (2026-2031) & (USD Million)
 Table 66. South America Drugs Based on CAR T-cell Consumption Value by Type (2020-2025) & (USD Million)
 Table 67. South America Drugs Based on CAR T-cell Consumption Value by Type (2026-2031) & (USD Million)
 Table 68. South America Drugs Based on CAR T-cell Consumption Value by Application (2020-2025) & (USD Million)
 Table 69. South America Drugs Based on CAR T-cell Consumption Value by Application (2026-2031) & (USD Million)
 Table 70. South America Drugs Based on CAR T-cell Consumption Value by Country (2020-2025) & (USD Million)
 Table 71. South America Drugs Based on CAR T-cell Consumption Value by Country (2026-2031) & (USD Million)
 Table 72. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Type (2020-2025) & (USD Million)
 Table 73. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Type (2026-2031) & (USD Million)
 Table 74. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Application (2020-2025) & (USD Million)
 Table 75. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Application (2026-2031) & (USD Million)
 Table 76. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Country (2020-2025) & (USD Million)
 Table 77. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Country (2026-2031) & (USD Million)
 Table 78. Global Key Players of Drugs Based on CAR T-cell Upstream (Raw Materials)
 Table 79. Global Drugs Based on CAR T-cell Typical Customers


List of Figures
 Figure 1. Drugs Based on CAR T-cell Picture
 Figure 2. Global Drugs Based on CAR T-cell Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Drugs Based on CAR T-cell Consumption Value Market Share by Type in 2024
 Figure 4. CD19-targeted
 Figure 5. BCMA-targeted
 Figure 6. Global Drugs Based on CAR T-cell Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 7. Drugs Based on CAR T-cell Consumption Value Market Share by Application in 2024
 Figure 8. Lymphoma Picture
 Figure 9. Multiple Myeloma Picture
 Figure 10. Global Drugs Based on CAR T-cell Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 11. Global Drugs Based on CAR T-cell Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 12. Global Market Drugs Based on CAR T-cell Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 13. Global Drugs Based on CAR T-cell Consumption Value Market Share by Region (2020-2031)
 Figure 14. Global Drugs Based on CAR T-cell Consumption Value Market Share by Region in 2024
 Figure 15. North America Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 16. Europe Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 17. Asia-Pacific Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 18. South America Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 19. Middle East & Africa Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global Drugs Based on CAR T-cell Revenue Share by Players in 2024
 Figure 22. Drugs Based on CAR T-cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 23. Market Share of Drugs Based on CAR T-cell by Player Revenue in 2024
 Figure 24. Top 3 Drugs Based on CAR T-cell Players Market Share in 2024
 Figure 25. Top 6 Drugs Based on CAR T-cell Players Market Share in 2024
 Figure 26. Global Drugs Based on CAR T-cell Consumption Value Share by Type (2020-2025)
 Figure 27. Global Drugs Based on CAR T-cell Market Share Forecast by Type (2026-2031)
 Figure 28. Global Drugs Based on CAR T-cell Consumption Value Share by Application (2020-2025)
 Figure 29. Global Drugs Based on CAR T-cell Market Share Forecast by Application (2026-2031)
 Figure 30. North America Drugs Based on CAR T-cell Consumption Value Market Share by Type (2020-2031)
 Figure 31. North America Drugs Based on CAR T-cell Consumption Value Market Share by Application (2020-2031)
 Figure 32. North America Drugs Based on CAR T-cell Consumption Value Market Share by Country (2020-2031)
 Figure 33. United States Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 34. Canada Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 35. Mexico Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 36. Europe Drugs Based on CAR T-cell Consumption Value Market Share by Type (2020-2031)
 Figure 37. Europe Drugs Based on CAR T-cell Consumption Value Market Share by Application (2020-2031)
 Figure 38. Europe Drugs Based on CAR T-cell Consumption Value Market Share by Country (2020-2031)
 Figure 39. Germany Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 40. France Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 41. United Kingdom Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 42. Russia Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 43. Italy Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 44. Asia-Pacific Drugs Based on CAR T-cell Consumption Value Market Share by Type (2020-2031)
 Figure 45. Asia-Pacific Drugs Based on CAR T-cell Consumption Value Market Share by Application (2020-2031)
 Figure 46. Asia-Pacific Drugs Based on CAR T-cell Consumption Value Market Share by Region (2020-2031)
 Figure 47. China Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 48. Japan Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 49. South Korea Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 50. India Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 51. Southeast Asia Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 52. Australia Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 53. South America Drugs Based on CAR T-cell Consumption Value Market Share by Type (2020-2031)
 Figure 54. South America Drugs Based on CAR T-cell Consumption Value Market Share by Application (2020-2031)
 Figure 55. South America Drugs Based on CAR T-cell Consumption Value Market Share by Country (2020-2031)
 Figure 56. Brazil Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 57. Argentina Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 58. Middle East & Africa Drugs Based on CAR T-cell Consumption Value Market Share by Type (2020-2031)
 Figure 59. Middle East & Africa Drugs Based on CAR T-cell Consumption Value Market Share by Application (2020-2031)
 Figure 60. Middle East & Africa Drugs Based on CAR T-cell Consumption Value Market Share by Country (2020-2031)
 Figure 61. Turkey Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 62. Saudi Arabia Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 63. UAE Drugs Based on CAR T-cell Consumption Value (2020-2031) & (USD Million)
 Figure 64. Drugs Based on CAR T-cell Market Drivers
 Figure 65. Drugs Based on CAR T-cell Market Restraints
 Figure 66. Drugs Based on CAR T-cell Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. Drugs Based on CAR T-cell Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Companies Mentioned

Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite